Dr. Nicholson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
165 Cambridge St
Ste 600
Boston, MA 02114Phone+1 617-726-4281
Education & Training
- Massachusetts General HospitalFellowship, Clinical Research Fellowship in Neurodegenerative Disorders, focus on ALS, 2014 - 2015
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Neuromuscular Medicine (Neurology), 2013 - 2014
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Neurology, 2010 - 2013
- George Washington University School of Medicine and Health SciencesClass of 2009
Certifications & Licensure
- MA State Medical License 2013 - 2026
- ME State Medical License 2021 - 2024
- NH State Medical License 2022 - 2024
- RI State Medical License 2022 - 2024
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Publications & Presentations
PubMed
- 2 citationsApilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trial.Suma Babu, Katharine A Nicholson, Jeffrey D Rothstein, Andrea Swenson, Paul J Sampognaro
Brain. 2024-09-03 - Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis.Ruxandra F Sîrbulescu, Katharine Nicholson, Kento Kawai, Orla M Hilton, Don Sobell
FASEB Journal. 2024-07-15 - 1 citationsDebamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes.Stacy R Lindborg, Namita A Goyal, Jonathan Katz, Matthew Burford, Jenny Li
Muscle & Nerve. 2024-06-01
Press Mentions
- Dosing Begins in Phase 2 Trial of AL001 in ALS with C9orf72 MutationsSeptember 13th, 2021
- The Human Gut Microbiota in People with Amyotrophic Lateral SclerosisJune 15th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: